semaglutide patent expiration date Ozempic's Key Molecule To Go Off-Patent: What Changes Now? Novo Nordisk to lose blockbuster

The FDA has approved specific GLP-1 formulations for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity

Simulated pharmacokinetics of inhaled caffeine and melatonin from existing products indicate the lack of dosimetric considerations

A remote monitoring system for artificial pancreas support is safe, reliable, and user friendly

Rifaximin Rifaximin, a non-absorbable gut-selective antibiotic, modulates intestinal enzymatic activity, thereby suppressing inflammatory cytokine production, improving gut barrier function, and maintaining intestinal homeostasis [124, 125]

Adhere to Ethical Guidelines: Always conduct research within established ethical frameworks and institutional review board protocols